The forum on personalized medicine and next-generation sequencing (NGS) technology was held at the Chinese National Compound Library (CNCL) in the afternoon of March 20, 2013. It was jointly chaired by Professor Ming-Wei Wang (Director of the National Center for Drug Screening, NCDS) and Professor Min Huang (Dean of School of Pharmacy, Sun Yat-Sen University). Over 10 participants from NCDS, PerkinElmer (USA), Hangzhou Chain Medical Labs, Inc., Shanghai Biotecan Medical Diagnostics Co., Ltd., LBD Life Sciences (China) Ltd., Illunina sales agent in China, Helixgen (Guangzhou) Co., Ltd. and ELIM BIOPHARM (USA) discussed the construction details of a NGS technology platform via this multilateral collaboration in personalized medicine.